Weiqi Lu
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- biodegradable polymer synthesis and properties
- Nanoparticle-Based Drug Delivery
Papers in
-
- Sarcoma Diagnosis and Treatment 28
- Co-authors
- Tae Gwan Park (3 shared papers)Ying Jiang (11 shared papers)George Crotts (1 shared paper)Cai‐Yuan Pan (11 shared papers)Yong Zhang (38 shared papers)Edward P. Kirby (3 shared papers)Hanxing Tong (38 shared papers)Ruke Bai (9 shared papers)
- Journals
- Frontiers in Oncology (7 papers)Oncotarget (4 papers)Journal of Clinical Oncology (4 papers)World Journal of Surgical Oncology (4 papers)International Journal of Molecular Sciences (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weiqi Lu
115 papers receiving 2.5k citations
Weiqi Lu's Hit Papers
Peers
Comparison fields: 5 of 125
- Pharmaceutical Science 238
- Biomaterials 283
- Cancer Research 233
- Molecular Medicine 79
- Hematology 164
Countries citing papers authored by Weiqi Lu
This map shows the geographic impact of Weiqi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqi Lu more than expected).
Fields of papers citing papers by Weiqi Lu
This network shows the impact of papers produced by Weiqi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqi Lu. The network helps show where Weiqi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiqi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 225 | |
| 2 | 2011 | 163 | |
| 3 | Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. | 1995 | 160 |
| 4 | 2014 | 157 | |
| 5 | 2004 | 128 | |
| 6 | 2018 | 113 | |
| 7 | 1993 | 97 | |
| 8 | 1991 | 78 | |
| 9 | 2009 | 75 | |
| 10 | 2013 | 60 | |
| 11 | 2019 | 44 | |
| 12 | 2015 | 43 | |
| 13 | 2004 | 41 | |
| 14 | 2019 | 37 | |
| 15 | 2020 | 37 | |
| 16 | Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization Hit paper breakdown → | 2025 | 37 |
| 17 | 1992 | 36 | |
| 18 | 2017 | 35 | |
| 19 | 2017 | 32 | |
| 20 | 1995 | 31 |
About Weiqi Lu
Weiqi Lu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Organic Chemistry, having authored 121 papers that have together received 2.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (28 papers), Advanced Polymer Synthesis and Characterization (12 papers), Gastrointestinal Tumor Research and Treatment (8 papers), Cancer-related molecular mechanisms research (7 papers), Platelet Disorders and Treatments (6 papers), Photopolymerization techniques and applications (6 papers), Vascular Tumors and Angiosarcomas (5 papers) and Cardiac tumors and thrombi (4 papers). The work is most often cited by research in Pharmaceutical Science (238 citations), Biomaterials (283 citations), Cancer Research (233 citations), Molecular Medicine (79 citations) and Hematology (164 citations). Weiqi Lu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Tae Gwan Park, Ying Jiang, George Crotts, Cai‐Yuan Pan, Yong Zhang, Edward P. Kirby, Hanxing Tong, Ruke Bai, Daoben Hua and Jun Zhu. Their work appears in journals such as Frontiers in Oncology, Oncotarget, Journal of Clinical Oncology, World Journal of Surgical Oncology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.